1. Home
  2. COEP vs MOBX Comparison

COEP vs MOBX Comparison

Compare COEP & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • MOBX
  • Stock Information
  • Founded
  • COEP 2017
  • MOBX 2020
  • Country
  • COEP United States
  • MOBX United States
  • Employees
  • COEP N/A
  • MOBX N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • MOBX
  • Sector
  • COEP Health Care
  • MOBX
  • Exchange
  • COEP Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • COEP 32.0M
  • MOBX 41.3M
  • IPO Year
  • COEP N/A
  • MOBX N/A
  • Fundamental
  • Price
  • COEP $9.15
  • MOBX $0.64
  • Analyst Decision
  • COEP
  • MOBX
  • Analyst Count
  • COEP 0
  • MOBX 0
  • Target Price
  • COEP N/A
  • MOBX N/A
  • AVG Volume (30 Days)
  • COEP 31.8K
  • MOBX 156.9K
  • Earning Date
  • COEP 05-14-2025
  • MOBX 06-10-2025
  • Dividend Yield
  • COEP N/A
  • MOBX N/A
  • EPS Growth
  • COEP N/A
  • MOBX N/A
  • EPS
  • COEP N/A
  • MOBX N/A
  • Revenue
  • COEP $62,874.00
  • MOBX $10,692,000.00
  • Revenue This Year
  • COEP N/A
  • MOBX N/A
  • Revenue Next Year
  • COEP N/A
  • MOBX N/A
  • P/E Ratio
  • COEP N/A
  • MOBX N/A
  • Revenue Growth
  • COEP N/A
  • MOBX 450.28
  • 52 Week Low
  • COEP $2.31
  • MOBX $0.55
  • 52 Week High
  • COEP $13.70
  • MOBX $2.49
  • Technical
  • Relative Strength Index (RSI)
  • COEP 46.80
  • MOBX 37.60
  • Support Level
  • COEP $8.95
  • MOBX $0.67
  • Resistance Level
  • COEP $9.85
  • MOBX $0.85
  • Average True Range (ATR)
  • COEP 0.64
  • MOBX 0.08
  • MACD
  • COEP -0.02
  • MOBX -0.01
  • Stochastic Oscillator
  • COEP 10.47
  • MOBX 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: